Max Healthcare ke Chairman Abhay Soi ne hospitals ki pricing par uthe sawalon ka jawab diya hai. Unka kehna hai ki bill sirf medicines ka nahi, balki complex clinical services ka hota hai. Filhal stock **52-week low** ke paas trade kar raha hai, jahan regulatory darr aur legal issues ne investors ki tension badha di hai.
Pricing par kya bole Abhay Soi?
Max Healthcare ke MD, Abhay Soi ne saaf kiya hai ki private hospitals ko sirf medicine retailer ki tarah nahi dekhna chahiye. Unhone explain kiya ki hospital ka bill medical supplies ka nahi, balki specialized training, climate-controlled storage, aur biomedical waste management jaisi services ka hota hai. Unke mutabik, inhi services ki wajah se operational costs manage hoti hain.
Net Profit aur Margins ka sach
Soi ne clarify kiya ki despite heavy markups ki baaton ke, bade hospital players ka net profit margin sirf 8% se 9% ke beech rehta hai. Yeh statement tab aaya hai jab judiciary aur state governments private hospitals ki billing practices par sakht nazrein banaye hue hain.
Investors ke liye kyun hai risk?
Supreme Court ke hospital markups par observations ke baad se poore sector mein bigyal-sa macha hai. Max Healthcare ka stock abhi 52-week low ke level par struggle kar raha hai. Investors ke liye ab do bade challenges hain:
- Expansion Plans: Company ₹6,000 Crore ka capital spend karke 2,800 nayi beds add karne ki planning mein hai, jisse total capacity 10,000 beds ho jayegi.
- Legal Trouble: Subsidiary Kalinga Hospital Ltd. ke khilaf BRS Capital ne NCLT mein proceedings shuru ki hain, jo share price ke liye ek aur sir-dard bana hua hai.
Regulatory price caps ka darr aur legal hurdles investors ke liye abhi bhi ek bada risk factor hain. Aane wale quarters mein dekhna hoga ki kya company apne profit margins maintain kar pati hai ya nahi.